Navigation Links
Ceremed Appoints Vice President for Sales and Business Development
Date:2/22/2008

LOS ANGELES, Feb. 22 /PRNewswire/ -- Ceremed, Inc., a medical device corporation, announced today that it has appointed Mr. Anthony Ruggiero as its new Vice President for Sales and Business Development. Mr. Ruggiero will join Ceremed and its affiliate corporation, Bioplate, Inc. at their Los Angeles corporate headquarters to direct global sales and strategic business development operations for both companies. He will assume his responsibilities on February 25th.

Mr. Ruggiero comes to Ceremed from Invibio, a biomaterials subsidiary of Victrex USA, where he served as the Americas and Asia Pacific Commercial Director. He was instrumental in developing Invibio's market for PEEK-OPTIMA, an implantable polymer material used in a variety of medical applications, including orthopedic and neurosurgical procedures. "We believe the combination of Mr. Ruggiero's market expertise, his established contacts with market leaders, and Ceremed's unique technology should allow him to create a substantial market for our company's new polymer products due to be launched this Spring," said Tadeusz Wellisz, M.D., President of Ceremed.

The planned launch of porous polyethylene maxillofacial implants coated with Ceremed's proprietary soluble Alkylene Oxide Copolymers (AOC) should benefit immediately from Mr. Ruggiero's industry connections and product knowledge. "The coating of the Porous Polyethylene (PPE) products with the AOC component will address the tissue grab problem, which currently limits the usefulness of existing products," said Dr. Wellisz. Other products planned for release include a line of AOC-coated porous metal implants designed to improve the ease of handling and application of the implants when they come into contact with human tissue.

"I very much look forward to bringing my experience and skills to Ceremed," said Mr. Ruggiero. "The company's cutting-edge technology has the potential to revolutionize the wound management and implant market. Alkylene Oxide Copolymers open tremendous possibilities in the development of soluble delivery systems for various therapeutic agents, from antibiotics to bone growth factors. I am very excited about the opportunity to make Ceremed's innovative products available to surgeons and their patients."

About the company:

Ceremed, Inc. is a privately held medical device corporation formed in 2002 by a surgeon and a group of scientists from the University of Southern California. The company has unique expertise and a portfolio of innovative proprietary technology in the field of soluble alkylene oxide copolymers. These polymers have multiple medical applications, including bone hemostasis and delivery system for a variety of therapeutic agents.

For additional information about the Company, please contact Danielle Nolan at 310-815-2125 or info@ceremed.com.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Tadeusz Wellisz http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=72918


'/>"/>
SOURCE Ceremed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
2. Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
3. AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors
4. Natural Alternatives International, Inc. Appoints New Chief Financial Officer
5. Deerfield Spa Appoints New Fitness Director
6. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
7. P\S\L Group appoints Paul Barnes as Group President P\S\L Research
8. AtriCure Appoints Mark A. Collar to its Board of Directors
9. Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
10. Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
11. Skinvisible Appoints New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... RICHEY, Fla. (PRWEB) , ... February 27, 2017 , ... ... disorder, but concern for women who become dependent on opioid painkillers has fallen short. ... female patients, compared to a 237% increase in fatal overdoses in male populations.(1) , ...
(Date:2/27/2017)... , ... February 27, 2017 , ... Orange County ... a chronic inflammatory gum condition that occurs when the bacteria in plaque infect the ... referred to as a scaling and root planing or SRP, and can include surgical ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – ... disclosed that despite scientific studies, the Center for Disease Control ( CDC ) and ... . Kenneth B. Liegner, M.D. has compiled into a single volume a compelling ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... announce a new informational post on robotic hair transplantation. San Francisco residents may ... transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment can be ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of ... concern over nerve agents and the deadly use of chemical weapons. Many questions exist ... how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... SEATTLE , Feb. 27, 2017  CTI BioPharma Corp. ... of Adam Craig , M.D., Ph.D., as President and ... Directors effective March 20, 2017. Dr. Craig succeeds Richard ... serve on the company,s Board of Directors.  Dr. Craig has ... development in both the US and Europe ...
(Date:2/27/2017)... -- Period October – December 2016 Revenues ... SEK -16.4 (-6.4) million Result after tax amounted to SEK ... dilution Cash flow from operating activities amounted to SEK -8.3 ... Period full year ... Operating result amounted to SEK -39.5 (-29.5) million ...
(Date:2/24/2017)... , Feb. 24, 2017  Today, exocad America ... labs have a new path to produce 510(K) ... Biodenta implant library integrated into exocad DentalCAD software. ... FDA compliant Good Manufacturing Processes (GMP,s) into their ... Biodenta, and complete an audit process. Then, dental labs ...
Breaking Medicine Technology: